title: [Trends in global antibiotic resistance].
abstract: Antibiotic resistance is an increasing problem world wide, although in some areas the increase in resistance is slow, as in the Nordic countries. Multiresistant staphylococci, Enterobaceriaceae and Mycobacterium tuberculosis are already causing increased morbidity, mortality and huge costs in health budgets. New effective antibiotics will not be available for the next 10-15 years, since the pharmaceutical industry has lost interest in antibiotics. The major determinant in this field, in order to save the activity of the known antibiotics, is the control of antibiotic use.
authors.affiliation: Statens Serum Institut, Afdeling for Antibiotikaresistens og Sygehushygiejne. nfm@ssi.dk
authors.forename: Niels
authors.initials: N
authors.lastname: Frimodt-Møller
authors.forename: Anette M
authors.initials: AM
authors.lastname: Hammerum
authors.forename: Line
authors.initials: L
authors.lastname: Bagger-Skjøt
authors.forename: Jonas Halfdan Ry
authors.initials: JH
authors.lastname: Hessler
authors.forename: Christian T
authors.initials: CT
authors.lastname: Brandt
authors.forename: Robert L
authors.initials: RL
authors.lastname: Skov
authors.forename: Dominique L
authors.initials: DL
authors.lastname: Monnet
mesh_terms: D024901:Drug Resistance, Multiple, Bacterial; D004363:Drug Utilization; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000401:mortality; D014943:Global Health; D017048:Health Care Costs; D006801:Humans; D016106:Methicillin Resistance; D010403:Penicillin Resistance; D011634:Public Health / Q000639:trends; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000401:mortality; D014376:Tuberculosis / Q000188:drug therapy / Q000401:mortality